Calcium electroporation for the treatment of basal cell carcinoma – a ‘Proof of concept’ study
A total of 25 patients with low risk primary basal cell carcinoma was treated in local anesthesia with injection of calcium chloride directly into the tumor including a safety margin of 5 mm, followed by electroporation with pulse frequencies of either 250 kHz or 5 kHz. The higher frequency was designed to limit muscle contraction during treatment. Histology proven non-complete responders were retreated after 3 months. Tumor demarcation, tumor depth and efficacy were evaluated using optical coherence tomography. Long term follow-up at 12 months were performed to evaluate the cosmetic outcome and recurrence rate.
Researcher
Consultant dermatologist Stine Regin Wiegell, PhD, MDSc
Project supervisors
Professor Merete Hædersdal
Professor Julie Gehl
Professor Gregor Jemec
Project period
Year: 2019 - 2022
Project collaborators
Professor Julie Gehl, Onkologisk afdeling, Sjællands Universitetshospital
Gregor Jemec, Dermatologisk afdeling, Sjællands Universitetshospital
Mirai Medical, Cork, Ireland
Financing
Department of Oncology, Sealand University Hospital
Department of Dermatology, Sealand University Hospital
Mirai Medical, Cork, Ireland
Udvalgte publikationer
Hendel K, Jemec GBE, Haedersdal M, Wiegell SR. Electrochemotherapy with bleomycin for basal cell carcinomas: A systematic review. JEADV 2021, acceptet for publication
Clover AJP, Salwa SP, Bourke MG et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol. 2020; 46:847-54.
Falk H, Matthiessen LW, Wooler G et al. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol. 2018; 57:311-19